Physician profile
Joan Addley
NPI 1275532160
$1,573.69
in general payments reported to CMS, 2019-2025
17 companies · $23.66 in 2025
The $23.66 reported for 2025 was less than what a typical Adolescent Medicine (Family Medicine) provider received nationally (typical 2025 total: $135).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.92 · 2021: $182 · 2022: $666 · 2023: $507 · 2024: $180 · 2025: $23.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $455.57 | 2021-2024 | Ubrelvy, Qulipta |
| Novo Nordisk INC | $324.73 | 2022-2023 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.47 | 2021-2023 | Jardiance |
| Abbott Laboratories | $141.96 | 2023-2025 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $78.97 | 2021-2022 | |
| Pfizer INC. | $67.33 | 2021-2023 | |
| Astellas Pharma US INC | $65.82 | 2023-2024 | Veozah |
| Exact Sciences Corporation | $58.25 | 2023 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $43.47 | 2024 | Voquezna |
| Lilly USA, LLC | $41.97 | 2021-2023 | Trulicity, Mounjaro |
| Glaxosmithkline, LLC. | $33.76 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $26.51 | 2022 | |
| Amgen INC. | $18.86 | 2023 | Repatha, Otezla |
| Amarin Pharma, INC. | $18.18 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $16.14 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.92 | 2020 | |
| Shield Therapeutics INC | $15.78 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Addley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.